Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on GEVA
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
SYNAGEVA BIOPHARMA (NQ:GEVA)
Delayed:
41.56
-0.72 (1.7%)
Trade Now!
Previous Close
$42.28
52 Week High
$58.00
Open
$42.22
52 Week Low
$36.35
Day High
$42.59
P/E
N/A
Day Low
$40.64
EPS
$-2.09
Volume
10,585
Friends, Peers and Foes
(?)
:
SUPN
,
ZGNX
,
PGNX
,
XOMA
,
MACK
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 13, 2013 05:28 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 11 Filed by: Patel Sanj K
Jun 10, 2013 05:21 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Williams Glen
Jun 10, 2013 05:18 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Baker/Tisch Investments, LP
Jun 10, 2013 05:07 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: WIRTH PETER
Jun 10, 2013 05:07 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: TISCH THOMAS J
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Patel Sanj K
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Quinn Anthony
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Quart Barry D
Jun 10, 2013 04:50 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Malley Thomas
Jun 10, 2013 04:50 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Goldberg Mark Alan
View All Articles
Mar 11, 2013 04:03 PM
Synageva Biopharma (GEVA) Posts Q4 Loss of 62c/Share
Mar 15, 2012 04:10 PM
Synageva Biopharma (GEVA) Misses Q4 EPS, Revenue Views
May 10, 2013 06:34 AM
JPMorgan Downgrades Synageva BioPharma (GEVA) to Neutral
Mar 12, 2013 11:31 AM
Leerink Swann Raises PT on Synageva BioPharma (GEVA) to $66
Mar 11, 2013 04:03 PM
Synageva Biopharma (GEVA) Posts Q4 Loss of 62c/Share
Jan 3, 2013 07:29 AM
Synageva BioPharma (GEVA) Announces $80M Common Offering
Jan 3, 2013 06:49 AM
Piper Jaffray Downgrades Synageva BioPharma (GEVA) to Neutral
Jan 2, 2013 05:53 PM
Janney Montgomery Scott Starts Synageva BioPharma (GEVA) at Neutral
Nov 12, 2012 08:09 AM
(AEGR) (GEVA) (MACK) (SUPN) (XOMA) (ZGNX) to be Added to NASDAQ Biotechnology Index (IBB)
Nov 12, 2012 06:29 AM
Synageva BioPharma (GEVA) Reports Encouraging Data from Sebelipase Alfa on LAL Deficiency
Sep 5, 2012 05:21 PM
Piper Jaffray Starts Synageva BioPharma (GEVA) at Overweight
Aug 3, 2012 10:31 AM
Canaccord Genuity Maintains a 'Buy' on Synageva BioPharma (GEVA); SBC-102 P1/2 Extension Data Next
View All Reports
Jun 5, 2013 07:30 AM
Synageva BioPharma™ to Present at the Goldman Sachs and Wells Fargo Healthcare Conferences
May 31, 2013 11:34 AM
Synageva BioPharma™ Announces Presentations and a Satellite Symposium at the National Lipid Association Meeting
May 22, 2013 02:53 PM
Synageva BioPharma™ to Present at the Jefferies 2013 Global Healthcare Conference
May 20, 2013 07:01 AM
Synageva's Sebelipase Alfa Receives Breakthrough Therapy Designation for Early Onset LAL Deficiency from the U.S. Food and Drug Administration
May 15, 2013 07:00 AM
Synageva BioPharma™ Joins the International MPS Network in Support of MPS Awareness Day 2013
May 9, 2013 07:01 AM
Synageva BioPharma™ Announces One Year of Treatment Data with Sebelipase Alfa in Late Onset LAL Deficiency
May 7, 2013 04:05 PM
Synageva BioPharma™ Reports First Quarter 2013 Financial Results
View All Press Releases
Jun 13, 2013 05:28 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 11 Filed by: Patel Sanj K
Jun 10, 2013 05:21 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Williams Glen
Jun 10, 2013 05:18 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Baker/Tisch Investments, LP
Jun 10, 2013 05:07 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: WIRTH PETER
Jun 10, 2013 05:07 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: TISCH THOMAS J
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Patel Sanj K
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Quinn Anthony
Jun 10, 2013 04:57 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Quart Barry D
Jun 10, 2013 04:50 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Malley Thomas
Jun 10, 2013 04:50 PM
Form 4 SYNAGEVA BIOPHARMA CORP For: Jun 06 Filed by: Heberlig Chris
View All Filings
Entities mentioned with
GEVA
Earnings
|
View Related Stories »
JPMorgan
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Canaccord Genuity
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Needham & Company
|
View Related Stories »
Janney Montgomery Scott
|
View Related Stories »
Longbow Research
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Trading Radar
|
View Related Stories »
PPI
|
View Related Stories »
Empire Manufacturing
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
CIBC
|
View Related Stories »
BMO Capital
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
ThinkEquity
|
View Related Stories »
Wells Fargo
|
View Related Stories »
Show More...
View All Entities